# Effectiveness of Lidocaine Injection on Stellate Ganglion in Pediatric Patients With Autism Spectrum Disorder

> **NCT06301685** · NA · UNKNOWN · sponsor: **Muhammad** · enrollment: 80 (estimated)

## Conditions studied

- Autistic Disorder

## Interventions

- **BEHAVIORAL:** Routine therapy
- **PROCEDURE:** Injection
- **DRUG:** Lidocaine Hydrochloride

## Key facts

- **NCT ID:** NCT06301685
- **Lead sponsor:** Muhammad
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301685, "Effectiveness of Lidocaine Injection on Stellate Ganglion in Pediatric Patients With Autism Spectrum Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06301685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*